Frontlight ResearchEarly access
Trial site
USC Norris Cancer Center
- 5running trials
- 8closed trials
The trials here
What the 13 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Ovarian cancer1 trial
- Phase
- Phase 36 trials
- Phase 14 trials
- Phase 22 trials
- Status
- Completed8 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Lead sponsor
- Hoffmann-La Roche4 trials
- Novartis Pharmaceuticals2 trials
- Protara Therapeutics2 trials
- BioNTech SE1 trial
- Buzzard Pharmaceuticals1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Endometrial cancer1 recruiting
Closed trials
Completed
Completed
Completed
A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Completed
Recruiting
Completed
Completed
Completed
Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers
Site data: ClinicalTrials.govUpdated 17 Nov 2026